About RestorGenex (NASDAQ:DFFN)
Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The Company's Diffusion's technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate, TSC, with standard-of-care radiation and chemotherapy regimens, thus effecting a better patient survival outcome without the addition of harmful side effects. Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types, with an initial focus on primary brain cancer (glioblastoma or GBM), pancreatic cancer, and brain metastases.
Industry, Sector and Symbol
Industry Bio Therapeutic Drugs
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value$0.89 per share
Price / Book1.61
Return on Equity-1,949.09%
Return on Assets40.65%
RestorGenex (NASDAQ:DFFN) Frequently Asked Questions
What is RestorGenex's stock symbol?
RestorGenex trades on the NASDAQ under the ticker symbol "DFFN."
When will RestorGenex make its next earnings announcement?
Who are some of RestorGenex's key competitors?
Some companies that are related to RestorGenex include Imprimis Pharmaceuticals (IMMY), Proteon Therapeutics (PRTO), Vical (VICL), Avacta Group (AVCT), ContraVir Pharmaceuticals (CTRV), Pain Therapeutics (PTIE), Redx Pharma (REDX), Kitov Pharmaceuticals (KTOV), Zosano Pharma (ZSAN), Orexigen Therapeutics (OREX), Aviragen Therapeutics (AVIR), Midatech Pharma (MTPH), Anthera Pharmaceuticals (ANTH), Eleven Biotherapeutics (EBIO), Auris Medical (EARS), Xenetic Biosciences (XBIO), Cerulean Pharma (DARE) and Ritter Pharmaceuticals (RTTR).
How do I buy RestorGenex stock?
Shares of RestorGenex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RestorGenex's stock price today?
One share of RestorGenex stock can currently be purchased for approximately $1.43.
How big of a company is RestorGenex?
RestorGenex has a market capitalization of $20.18 million. The company earns $-18,030,000.00 in net income (profit) each year or ($3.83) on an earnings per share basis. RestorGenex employs 10 workers across the globe.
How can I contact RestorGenex?
RestorGenex's mailing address is 1317 CARLTON AVENUE SUITE 400, CHARLOTTESVILLE VA, 22902. The company can be reached via phone at 434-220-0718 or via email at [email protected]
MarketBeat Community Rating for RestorGenex (DFFN)MarketBeat's community ratings are surveys of what our community members think about RestorGenex and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
RestorGenex (NASDAQ:DFFN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for RestorGenex (NASDAQ:DFFN)
No earnings announcements for this company have been tracked by MarketBeat.com
RestorGenex (NASDAQ:DFFN) Earnings Estimates
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for RestorGenex (NASDAQ:DFFN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for RestorGenex (NASDAQ DFFN)
No insider trades for this company have been tracked by MarketBeat.com
RestorGenex (NASDAQ DFFN) News Headlines
RestorGenex (NASDAQ:DFFN) SEC Filings
RestorGenex (NASDAQ:DFFN) Income Statement, Balance Sheet and Cash Flow Statement
RestorGenex (NASDAQ DFFN) Stock Chart for Tuesday, December, 12, 2017